Completed PHASE2 INTERVENTIONAL 1-arm NCT00528710

Efficacy of S-Adenosylmethionine in Fibromyalgia

Double-Blind, Placebo-Controlled Trial of the Impact of S-Adenosyl-L-Methionine (SAM-e) on the Mood and Other Symptoms in Fibromyalgia

Sponsor: Deakin University

Conditions Fibromyalgia Syndrome

Interventions SAM-e (S-Adenosyl-L-Methionine)

Updated 4 times since 2017 Last updated: Sep 11, 2007 Started: Nov 30, 2006 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00528710, this PHASE2 trial focuses on Fibromyalgia Syndrome and remains completed. Sponsored by Deakin University, it has been updated 4 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2017 — Jan 2021 [monthly]

Completed PHASE2

First recorded

Nov 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Deakin University

Data source: Deakin University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Burwood, Australia